Abstracts tagged "chronic low back pain and cross-sectional studies"

Abstract Number: 2264 • 2015 ACR/ARHP Annual Meeting
Prevalence and Social Burden of Active Chronic Low Back Pain in the Adult Portuguese Population – Results from a National Survey
Nelia Gouveia^1,2, Ana M. Rodrigues^1,3,4,5, Monica Eusebio⁶, Pedro Machado^1,7,8, Sofia Ramiro^1,5,9, Helena Canhao^1,10,11 and Jaime C Branco^1,5,12,13, ¹EpiReumaPt Study Group, Lisbon, Portugal, ²CEDOC - Chronic Diseases FCM NOVA, NOVA Medical School - Faculdade Ciências Médicas da UNL, Lisbon, Portugal, ³Rheumatology Research Unit, Instituto de Medicina Molecular and Rheumatology and Bone Metabolic Diseases Department, Hospital de Santa Maria, Lisbon, Portugal, ⁴Faculdade de Medicina a Universidade de Lisboa, Lisbon, Portugal, ⁵CEDOC - Chronic Diseases FCM NOVA, NOVA Medical School - Faculdade de Ciências Médicas da UNL, Lisbon, Portugal, ⁶Portuguese Society of Rheumatology, Lisbon, Portugal, ⁷University College London - MRC Centre for Neuromuscular Diseases,, London, United Kingdom, ⁸Clínica Universitária de Reumatologia, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, ⁹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ¹⁰Rheumatology Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal on behalf of the Rheumatic Diseases Portugal Register, Lisbon, Portugal, ¹¹Hospital Santa Maria - Serviço de Reumatologia, Lisboa, Portugal, ¹²Serviço de Reumatologia do Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental (CHLO- E.P.E.), lisbon, Portugal, ¹³NOVA Medical School/faculdade de ciências médicas, Universidade Nova de Lisboa, Lisboa, Portugal
Background/Purpose: The prevalence and burden of chronic low back pain (CLBP) were ill defined in Portugal. The aim of this study was to determine, the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].